MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0)
|
Basic information |
| Metabolite name | MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0) |
 | HMDB0004666 |
 |
C13856 |
 |
5282280 |
| Synonyms | 2-arachidonoylglycerol; |
| No. of studies | 23 |
|
Basic information |
| Metabolite name | MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0) |
| HMDB0004666 |
|
C13856 |
|
5282280 |
| Synonyms | 2-arachidonoylglycerol; |
| No. of studies | 23 |
|
Relationship between MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0) and depression (count: 23) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1073 | Type1 | BDE47 exposure group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M160 | Type1 | CUMS group vs. control group | Adipose tissue | Sprague-Dawley rat | Up |
| Study M160 | Type2 | CUMS + CWD group vs. CUMS group | Adipose tissue | Sprague-Dawley rat | Down |
| Study M185 | Type1 | depressed group vs. control group | Serum | Human | Down |
| Study M186 | Type1 | depressed group vs. control group | Serum | Human | Down |
| Study M197 | Type1 | CUS group vs. control group | Hippocampus | Long-Evans rat | Down |
| Study M198 | Type1 | CUS group vs. control group | Hypothalamus | Long-Evans rat | Up |
| Study M198 | Type1 | CUS group vs. control group | Midbrain | Long-Evans rat | Up |
| Study M201 | Type1 | CUS group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M202 | Type1 | depression group vs. control group | Serum | Human | Down |
| Study M206 | Type1 | bulbectomized group vs. sham group | Prefrontal cortex | Wistar rat | Up |
| Study M206 | Type1 | bulbectomized group vs. sham group | Nucleus accumbens | Wistar rat | Down |
| Study M206 | Type1 | WKY group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Up |
| Study M496 | Type1 | CMS group vs. control group | Thalamus | Wistar rat | Up |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | acute N-acetylcysteine group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M498 | Type3 | chronic URB597 group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | acute imipramine group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | acute imipramine group vs. control group | Frontal cortex | Wistar rat | Up |
| Study M498 | Type3 | acute URB597 group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Frontal cortex | Wistar rat | Down |
| Study M498 | Type3 | acute N-acetylcysteine group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Frontal cortex | Wistar rat | Up |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | acute escitalopram group vs. control group | Frontal cortex | Wistar rat | Down |
| Study M498 | Type3 | chronic imipramine group vs. control group | Frontal cortex | Wistar rat | Up |
| Study M498 | Type3 | chronic imipramine group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Nucleus accumbens | Wistar rat | Down |
| Study M498 | Type3 | chronic tianeptine group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | chronic imipramine group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Hippocampus | Wistar rat | Up |
| Study M498 | Type3 | chronic tianeptine group vs. control group | Frontal cortex | Wistar rat | Up |
| Study M499 | Type3 | tranylcypromine group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M506 | Type1 | CMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M506 | Type2 | CMS + rTMS group vs. CMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M548 | Type1 | FSL group vs. FRL group, left hippocampus | Hippocampus | Sprague-Dawley rat | Down |
| Study M548 | Type1 | FSL group vs. FRL group | Plasma | Sprague-Dawley rat | Down |
| Study M548 | Type1 | FSL group vs. FRL group, left prefrontal cortex | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M609 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M705 | Type1 | maternal separation group vs. control group | Prefrontal cortex | C57BL/6 mouse | Down |
| Study M717 | Type3 | citalopram group vs. control group, at week 4 | Hippocampus | Wistar rat | Up |
| Study M717 | Type3 | citalopram group vs. control group, at week 4 | Amygdala | Wistar rat | Up |
| Study M717 | Type3 | citalopram group vs. control group, at week 4 | Frontal cortex | Wistar rat | Up |
| Study M717 | Type3 | nortriptyline group vs. control group, at week 4 | Frontal cortex | Wistar rat | Up |
| Study M717 | Type3 | nortriptyline group vs. control group, at week 4 | Hippocampus | Wistar rat | Up |
| Study M834 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M887 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M888 | Type1 | CUMS microbiota group vs. control microbiota group | Hippocampus | C57BL/6J mouse | Down |
| Study M888 | Type2 | CUMS microbiota + L. plantarum Lp group vs. CUMS microbiota group | Hippocampus | C57BL/6J mouse | Up |
| Study M888 | Type2 | CUMS microbiota + arachidonic acid group vs. CUMS microbiota group | Hippocampus | C57BL/6J mouse | Up |
| Study M927 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M927 | Type2 | CUMS + Zhi-zi-chi decoction group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
| Study M993 | Type1 | depression group vs. control group | Plasma | Human | Up |